Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep 1;73(17):5315-9.
doi: 10.1158/0008-5472.CAN-13-1069. Epub 2013 Jun 3.

Patient-derived tumor xenografts: transforming clinical samples into mouse models

Despina Siolas  1 , Gregory J Hannon
Affiliations
Review

Patient-derived tumor xenografts: transforming clinical samples into mouse models

Despina Siolas et al. Cancer Res. .

Abstract

Tumor graft models (also known as patient-derived xenografts or PDX) are based on the transfer of primary tumors directly from the patient into an immunodeficient mouse. Because PDX mice are derived from human tumors, they offer a tool for developing anticancer therapies and personalized medicine for patients with cancer. In addition, these models can be used to study metastasis and tumor genetic evolution. This review examines the development, challenges, and broad use of these attractive preclinical models.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer research. 2009;69:3364–3373. - PMC - PubMed
    1. Sausville EA, Burger AM. Contributions of human tumor xenografts to anticancer drug development. Cancer research. 2006;66:3351–3354. discussion 4. - PubMed
    1. Boedigheimer MJ, Freeman DJ, Kiaei P, Damore MA, Radinsky R. Gene expression profiles can predict panitumumab monotherapy responsiveness in human tumor xenograft models. Neoplasia. 2013;15:125–132. - PMC - PubMed
    1. Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nature protocols. 2009;4:1670–1680. - PMC - PubMed
    1. Rubio-Viqueira B, Hidalgo M. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients. Clinical pharmacology and therapeutics. 2009;85:217–221. - PubMed